Perfil
Micah Zajic worked as a Senior Director of Corporate Strategy at Alexion Pharmaceuticals, Inc. from 2014 to 2017.
He then served as the Vice President of Corporate Development at MeiraGTx Ltd. from 2017 to 2020.
In 2020, he joined SQZ Biotechnologies Co. as the Chief Financial Officer for a year.
In 2023, he briefly worked as the Chief Business Officer at Lexeo Therapeutics, Inc. Mr. Zajic completed his undergraduate degree at Georgetown University.
Antiguos cargos conocidos de Micah Zajic.
| Empresas | Cargo | Fin |
|---|---|---|
| LEXEO THERAPEUTICS, INC. | Director Financiero/CFO | 01/07/2023 |
| SQZ BIOTECHNOLOGIES COMPANY | Director Financiero/CFO | 31/12/2022 |
MeiraGTx Ltd.
MeiraGTx Ltd. Pharmaceuticals: MajorHealth Technology Develops novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders | Corporate Officer/Principal | 01/09/2020 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2017 |
Formación de Micah Zajic.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
SQZ Biotechnologies Co.
SQZ Biotechnologies Co. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cell therapies for patients with cancer, infectious diseases and serious conditions | Health Technology |
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MeiraGTx Ltd.
MeiraGTx Ltd. Pharmaceuticals: MajorHealth Technology Develops novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders | Health Technology |
Lexeo Therapeutics Inc
Lexeo Therapeutics Inc BiotechnologyHealth Technology Develops gene therapy to treat genetic diseases | Health Technology |
- Bolsa de valores
- Insiders
- Micah Zajic
















